Unveiling the Benefits 1
Much less certain is the potential effects that diuretics may have on renal glucose production
Semaglutide is a GLP-1 receptor agonist, which helps to regulate blood sugar by enhancing insulin secretion, slowing gastric emptying, and promoting satiety
But after burning through some $50 million developing the drug, Metabolic Pharmaceuticals Pty Ltd, which owns the patent, has continued to spruik its so-called body-enhancing benefits
The primary focus of the EllieMD programs, however, are on supporting overall metabolic health, lowering the risk of chronic disease, and promoting long-term resilience
Patients also often notice temporary bouts of fatigue when starting the drug